Interferon-free Regimen for Genotype-4 Chronic Hepatitis CInterferon-free Regimen for Genotype-4 Chronic Hepatitis C

An all-oral, interferon-free regimen consisting of ombitasvir, paritaprevir and ritonavir is effective at treating patients with genotype-4 chronic hepatitis C virus (HCV), according to a new report from AbbVie. Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Infectious Diseases News Source Type: news

Related Links:

About a dozen states have added hepatitis C to the list of medical conditions for which people can face criminal prosecution if they knowingly engage in activities that could spread the disease.(Image credit: James Cavallini/Science Source)
Source: NPR Health and Science - Category: Consumer Health News Authors: Source Type: news
This study aims to determine whether hepatitis B virus (HBV) or hepatitis C virus (HCV) inf...
Source: Journal of Translational Medicine - Category: Research Authors: Tags: Research Source Type: research
Publication date: July 2018 Source:American Journal of Kidney Diseases, Volume 72, Issue 1 Author(s): Deirdre Sawinski, Kimberly A. Forde, Christina M. Wyatt
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
Conclusions Treatment with DAAs reduces liver stiffness, but is associated with increase in hepatic steatosis.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
Conclusion The present study established a positive co-relation between malnutrition, HBsAg carrier, HIV infection, NAT2 slow acetylators, GSTM1 null mutation, GSTT1 null mutation and ATT induced hepatitis.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
The newest HCV guidance is out on special populations. Are you up to date? Take our short, 5-question quiz to find out.  
Source: ConsultantLive - Category: Internal Medicine Authors: Tags: Hepatitis C Source Type: news
Condition:   Hepatitis C Intervention:   Sponsor:   Yale University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Authors: Attallah AM, Omran D, Marie MS, Abdelrazek MA, Salama A, El Essawey R, Mobarak L, Maklad S, Omar A Abstract BACKGROUND: A single nucleotide polymorphism (SNP) in the interleukin 28B (IL28B) gene may alter the trajectory of hepatitis C virus (HCV) chronic infection. Several studies have sought to determine a link between the IL28B rs12979860 SNP and the development of HCV-related hepatocellular carcinoma (HCC), but with variable results, consensus is awaited. We hypothesised that IL28B rs12979860 SNP is linked to HCC in patients with HCV type 4. METHODS: IL28B genotyping of 300 patients with HCV related...
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research
Florian Wrensch, Emilie Crouchet, Gaetan Ligat, Mirjam B. Zeisel, Zhen-Yong Keck, Steven K. H. Foung, Catherine Schuster, Thomas F. Baumert
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
A Pennsylvania state court has allowed a lawsuit to move ahead against the...Read more on AuntMinnie.comRelated Reading: ARRT responds to Newsweek article on Kwiatkowski Former RT Kwiatkowski reveals drug diversion secrets Kwiatkowski sentenced to 39 years in prison Kwiatkowski pleads guilty in hepatitis C case NH report slams Exeter Hospital procedures in hepatitis C outbreak
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Gastroenterology | Health | Hepatitis | Hepatitis C | Infectious Diseases | Norvir